Bastide le Confort Medical SABLC:PAR

17.22
0.280 / 1.6 %
4.69k
7.9 %
0.49
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Feb 10 2016 16:28 GMT.

About the company

171.17m6.80m19761.32k
Revenue in EUR (TTM)Net income in EURIncorporatedEmployees
IndustryHealth Care Equipment & ServicesLocation
Bastide le Confort Medical SA
Centre d'activite Euro 2000
12 avenue de la Dame
CAISSARGUES30132
France
FRA
Phone+33 466386808Fax+33 466386809Websitehttp://www.bastideleconfortmedical.com/
Bastide le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for elderly, sick or handicapped people, for healthcare professionals and individual clients. The Company’s product and services are divided into three divisions: home care equipment and services like wheelchairs, ergonomic pillows, anti-bedsore supports, self-diagnostic equipment and personal assistance products; perfusion and nutrition equipment and services like perfusion instruments, insulin pumps and syringe-drivers and respiratory assistance equipment and services like respirators, oxygen concentrators and oxygen tanks. In addition, the Company is involved in the rental and maintenance of medical equipment, such as insulin pumps, ventilators and nutrition check instruments. In July 2014, it acquired 66% of Societe S'Care Assistance's share capital.

Mergers & acquisitions

Acquired company
Deal status
DateBLC:PAR since
announced
Transaction
value
Cicadum SARLDeal completed06 Jul 2015+4.9 %--
Cica + SASUDeal completed12 May 2015+6.9 %--
Data delayed at least 15 minutes, as of Feb 10 2016 16:28 GMT.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Diagnostic Medical Systems (DMS) SA
30.66m-975.00k29.09m88--1.23--0.9487-0.009-0.0090.31630.1550.99843.043.95---4.083-15.889-6.3017-15.88919.1013.48-4.0898-9.10371.84--0.1691--10.608.49-14.2122--15.27--
Mauna Kea Technologies SAS
11.91m-14.16m34.94m109--1.98--2.93-0.9965-0.99650.8391.090.411.443.6799,283.34-48.7243-32.0256-60.2861-32.025670.7472.53-118.8518-111.46193.47-232.27870.1521--12.5217.53-21.4918---5.546--
Visiomed Group SA
13.76m-4.57m43.66m85--3.97--3.17-0.7782-0.77822.431.051.004.818.23172,053-33.2796-34.6237-63.9342-34.62375.8323.18-33.2102-20.25041.00--0.1189--18.09178.920.3973------
Medicrea International SA
26.16m-1.97m44.03m134--2.8521.841.68-0.2288-0.22883.041.720.91871.735.59204,349-6.9151-8.2094-9.6369-8.209458.3762.99-7.5272-6.41491.38-3.52940.4278--5.9013.08-317.3281--12.92--
Crossject SA
0-5.81m45.56m12--4.17-----0.8731-0.87310.001.640.00-------33.2803---41.1615----------2.56--0.00-------137.9084------
Stentys SAS
4.52m-10.06m47.88m39--2.80--10.59-0.8764-0.87640.39411.400.15991.332.49115,926-35.5881-42.0398-46.2871-42.039847.6542.03-222.5995-502.05112.99--0.0577--13.48---52.054---19.7995--
EOS Imaging SA
23.14m-3.96m53.64m106--2.07--2.32-0.2149-0.21491.261.280.5803.521.70218,283-9.9132---12.5448--50.34---17.0931--3.26--0.2623--32.25--10.86------
Medtech SA
6.52m-2.63m58.71m31--3.77--9.01-1.0991-1.09912.736.520.333810.412.57211,605-13.4472---15.0562---2.6299---40.2895--7.04--0.0358--158.20---31.1628------
Pixium Vision SA
3.30m-15.68m60.51m32--1.73--18.36-1.2315-1.23150.25922.750.0705-------33.4398---36.3744-------474.6043----------35.84---34.7268------
Vexim SA
11.52m-6.13m61.71m29--4.59--5.36-0.9637-0.96371.811.760.75044.174.02397,345-39.9323-99.8699-50.8163-99.869913.28-43.2524-53.2153-141.69412.85-1,435.000.018--67.75--10.43------
Bastide Le Confort Medical SA
171.17m6.80m128.46m1.32k18.892.394.950.75050.92640.926423.327.341.155.236.07129,3784.716.688.036.6844.8343.034.093.370.69466.650.525331.6012.5111.3632.9418.9521.3417.84
Carmat SA
0-16.54m142.25m45---------3.6781-3.67810.00-1.08150.00----0.00-128.7645-85.7796-207.3105-85.7796-----------26.3579---------24.7059---32.6198--
Amplitude Surgical SAS
71.09m-17.65m163.79m248--1.38--2.30-0.4403-0.44031.512.540.33691.333.82286,653-8.3991---10.6684--45.33---24.929--1.700.2260.4125--22.09---520.0632------
Data as of Feb 11 2016. Currency figures normalised to Bastide le Confort Medical SA's reporting currency: Euro EUR.

Institutional shareholders

HolderShares% Held
Lazard Frères Gestion SAS
as of 26 Feb 2015
365.33k5.0%
Amundi Asset Management SA (Investment Management)
as of 31 Dec 2015
89.89k1.2%
Portzamparc Gestion SA
as of 30 Nov 2015
70.00k1.0%
Tocqueville Finance SA
as of 30 Nov 2015
63.88k0.9%
CI Global Investments, Inc.
as of 30 Jun 2015
55.00k0.7%
Palatine Asset Management SA
as of 29 Jan 2016
49.50k0.7%
HSBC Global Asset Management (France) SA
as of 30 Nov 2015
38.36k0.5%
Raymond James Asset Management International SA
as of 31 Dec 2014
37.00k0.5%
Valeco Finance SA
as of 30 Sep 2015
31.13k0.4%
UBS Asset Management France SA
as of 29 Jan 2016
30.07k0.4%
11.3%
Per cent of shares
held by top holders
Data from 31 Dec 2014 - 31 Jan 2016Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.